Transaction Details

Footnotes

Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,937 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024. | Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock | On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,937 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4.